Amyris, Inc. Set To Increase Global Growth Of Its Cosmetic Emollients Through ISO 22716 Certification
EMERYVILLE, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that in support of customer requirements for increasing sales to key markets globally, it has successfully achieved certification by the International Organization for Standardization's (ISO) highest Cosmetic standard -- 22716 for Good Manufacturing Standards (GMP) with its manufacturing partner, Glycotech, Inc. This certification of the Glycotech facility, granted on July 2, 2015, enables Amyris's B2B and B2C cosmetics businesses to more readily access high potential markets, with customers being assured that the company's Neossance® (www.neossance.com) and Biossance® (www.biossance.com) high-performance emollients are produced to the exacting quality and purity standards demanded for cosmetics.
Numerous cosmetics suppliers and brands have reached this same conclusion after conducting their own audits of Glycotech's manufacturing operations. Today, over 440 leading brands incorporate Amyris's high-performance cosmetic ingredients into their own products. Having received certification, Amyris believes its addressable cosmetic growth opportunities are now significantly broadened, particularly in instances where ISO 22716 enables increased market access to new customers.
ISO 22716 is an international standard that provides guidelines for the production, control, storage and distribution of cosmetic products. As a result, companies that have demonstrated GMP standards typically have a greater ability to pursue market penetration in markets where ISO certification provides a competitive advantage.
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as Amyris's belief that markets and growth opportunities for its cosmetics ingredients are set to expand or have been significantly broadened due to ISO certification), that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on August 10, 2015. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris, the Amyris logo, Neossance and Biossance are registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.
CONTACT: Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 email@example.com firstname.lastname@example.org
Help employers find you! Check out all the jobs and post your resume.